4//SEC Filing
Strem Brian M. 4
Accession 0001372514-23-000035
CIK 0001372514other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 8:15 PM ET
Size
7.5 KB
Accession
0001372514-23-000035
Insider Transaction Report
Form 4
Strem Brian M.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-03-03$3.83/sh+15,600$59,748→ 28,783 total - Award
Stock Option (right to buy)
2023-03-03+10,400→ 10,400 totalExercise: $3.83Exp: 2033-03-03→ Common Stock (10,400 underlying)
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date.
- [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001876429
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 8:15 PM ET
- Size
- 7.5 KB